UAE Respiratory Devices Market Size (2024 - 2029)

UAE Respiratory Devices Market Analysis

The United Arab Emirates (UAE) respiratory devices market is expected to register a CAGR of 2.5% during the forecast period.

Respiratory devices, such as ventilators, nebulizers, and other respiratory devices, had an immense need to manage COVID-19 patients. COVID-19 had worse outcomes for patients with respiratory diseases. For instance, according to the study published in PLOS ONE Journal in March 2021, patients from the UAE with prior comorbidities, including asthma, COPD, and chronic renal disease, had a higher mortality rate during hospitalization. Thus, the demand for respiratory devices increased during the pandemic in the UAE. However, post-pandemic, the market is expected to gain traction over the coming years because of declining COVID-19 cases and the resumption of hospital services.

The market is driven by factors such as the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), tuberculosis (TB), asthma, sleep apnea, and technological advancements. For instance, according to the study published in the World Allergy Organization Journal in January 2022, the incidence of asthma in the United Arab Emirates was 13.5%. The increasing incidence of asthma in the United Arab Emirates is due to the presence of airborne pathologies due to changes in the weather conditions in the country. Hence, the demand for respiratory devices is expected to increase in the United Arab Emirates over the forecast period. Moreover, according to the study published in the World Allergy Organization Journal in October 2021, the prevalence of asthma, wheezing, and hay fever was higher in the 6- to 7-year-old group, while allergic rhinitis and atopic dermatitis were higher in the 13- to 14-year-old group in the UAE.

Furthermore, increasing R&D expenditure by innovators and generic players and technological advancements associated with respiratory devices are expected to fuel the UAE respiratory devices market. For instance, in January 2022, at Arab Health 2022, OES Medical debuted the ICU Ventilator. The Gemini-G100 is an electrically powered piston ICU ventilator with an integrated oxygen concentrator. The gadget was created for use in environments where a high-pressure oxygen supply is an issue.

Thus, all the aforementioned factors, such as the growing burden of chronic diseases and technological advancement, are expected to boost market growth over the forecast period. However, the high costs associated with the devices may hamper the market to a certain extent.

UAE Respiratory Devices Industry Segmentation

As per the scope, respiratory devices comprise respiratory diagnostic devices, therapeutic devices, and breathing devices for administering long-term artificial respiration. It also includes a breathing apparatus used for resuscitation by forcing oxygen into the lungs of a person who has undergone asphyxia. The UAE Respiratory Devices Market is segmented by Type (Diagnostic and Monitoring Devices (Spirometers, Sleep Test Devices, Peak Flow Meters, Pulse Oximeters, and others), Therapeutic Devices (CPAP Devices, BiPAP Devices, Humidifiers, Nebulizers, Ventilators, Oxygen Concentrators, Inhalers, and Others) and Disposables (Masks, Breathing Circuits, and Others)). The report offers the value (in USD million) for the above segments.